Education
About Us
Working with TipRanks
Follow Us
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
NATCOPHARM Analyst Ratings
Moderate Sell
0 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NATCOPHARM Stock 12 Month Forecast
Average Price Target
₹890.00
▼(-4.84% Downside)
| Highest Price Target₹890.00 | Average Price Target₹890.00 | Lowest Price Target₹890.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
₹1,086
Buy
16.11%
Upside
Reiterated
07/26/25
NATCO Pharma Limited's stock is rated well due to its strong financial performance and attractive valuation. The company shows robust revenue growth and profitability, with effective cash management and low leverage. Technical indicators are mixed, suggesting some caution, but the stock's low P/E ratio indicates it may be undervalued. Absence of earnings call data and significant corporate events means these factors did not influence the score.
ICICI Securities
₹890
Sell
-4.84%
Downside
Downgraded
07/24/25
Dolat Capital
₹1,458→₹913
Sell
-2.38%
Downside
Downgraded
02/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
₹1,086
Buy
16.11%
Upside
Reiterated
07/26/25
NATCO Pharma Limited's stock is rated well due to its strong financial performance and attractive valuation. The company shows robust revenue growth and profitability, with effective cash management and low leverage. Technical indicators are mixed, suggesting some caution, but the stock's low P/E ratio indicates it may be undervalued. Absence of earnings call data and significant corporate events means these factors did not influence the score.
ICICI Securities
₹890
Sell
-4.84%
Downside
Downgraded
07/24/25
Dolat Capital
₹1,458→₹913
Sell
-2.38%
Downside
Downgraded
02/14/25
Best Analysts Covering NATCO Pharma Limited
1 Month
xxx
Success Rate
1/1 ratings generated profit
Average Return
+11.40%
downgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +11.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+7.10%
downgraded a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.10% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+8.00%
downgraded a sell rating 16 days ago
Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.00% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+7.10%
downgraded a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +7.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NATCOPHARM Analyst Recommendation Trends
Rating
Feb 25
May 25
Jul 25
Strong Buy
0
0
0
Buy
1
1
5
Hold
0
1
1
Sell
1
1
2
Strong Sell
0
0
0
total
2
3
8
Each month's total comprises the sum of three months' worth of ratings.
NATCOPHARM Financial Forecast
NATCOPHARM Stock Forecast FAQ
What is IN:NATCOPHARM’s average 12-month price target, according to analysts?
Based on analyst ratings, NATCO Pharma Limited’s 12-month average price target is 890.00.
What is IN:NATCOPHARM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:NATCOPHARM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NATCO Pharma Limited a Buy, Sell or Hold?
NATCO Pharma Limited has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.
What is NATCO Pharma Limited’s share price target?
The average share price target for NATCO Pharma Limited is 890.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹890.00 ,and the lowest forecast is ₹890.00. The average share price target represents -4.84% Decrease from the current price of ₹935.3.
The highest analyst share price target is ₹890.00 ,and the lowest forecast is ₹890.00. The average share price target represents -4.84% Decrease from the current price of ₹935.3.
What do analysts say about NATCO Pharma Limited?
NATCO Pharma Limited’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of NATCO Pharma Limited?
To buy shares of IN:NATCOPHARM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.